QuickView for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=F814328285108F7A4EA0DA28CFE696D7;jsessionid=502E776C630F24248151AAEED05D5B46;jsessionid=3D6E4177C1A2C936A25F58E22CF119FE;jsessionid=345F3C3E31C12C444C4BFB6C7444F45F;jsessionid=BD9211D0409253AA8F0D3B430F1ADC06;jsessionid=D403D3E54AA99D43E2684D1717F9252B;jsessionid=4C13075FDE523DD686C62D0E6BD377B0;jsessionid=4E953FF874DD59730EA9FAD7FB982A85 (gene)

1. ATXN2 intermediate expansions in amyotrophic lateral sclerosis.
2. Missense mutation in ATXN2 gene (c.2860C > T) in an amyotrophic lateral sclerosis patient with aggre…
3. The RNA-binding protein and stress granule component ATAXIN-2 is expressed in mouse and human tissue…
4. Ataxin-2 gene: a powerful modulator of neurological disorders.
5. Antagonistic roles for Ataxin-2 structured and disordered domains in RNP condensation.

There were no clinical trials for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=F814328285108F7A4EA0DA28CFE696D7;jsessionid=502E776C630F24248151AAEED05D5B46;jsessionid=3D6E4177C1A2C936A25F58E22CF119FE;jsessionid=345F3C3E31C12C444C4BFB6C7444F45F;jsessionid=BD9211D0409253AA8F0D3B430F1ADC06;jsessionid=D403D3E54AA99D43E2684D1717F9252B;jsessionid=4C13075FDE523DD686C62D0E6BD377B0;jsessionid=4E953FF874DD59730EA9FAD7FB982A85